Page 3 - Johnson & Johnson

Johnson & Johnson forecasts $2.5 bn in Covid-19 vaccine sales this year

(Reuters) - Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.

US states to unveil $26 bn opioid settlement with drug distributors, J&J

(Reuters) - U.S. state attorneys general are expected this week to unveil a $26 billion settlement resolving claims that three major drug distributors and drugmaker Johnson & Johnson helped fuel a nationwide opioid epidemic, people familiar with the matter said on Monday.

J&J recalls Aveeno, Neutrogena sunscreens after carcinogen found in sprays

J&J is also notifying distributors and retailers to stop selling the products and arranging for their return 'out of an abundance of caution'

J&J recalls Aveeno, Neutrogena sunscreens after carcinogen found in sprays

(Reuters) - Johnson & Johnson said on Wednesday it is voluntarily recalling all lots of five Neutrogena and Aveeno brand aerosol sunscreen products from the market after detecting a cancer-causing chemical in some samples.

FDA adds warning of rare neurological reaction to J&J Covid-19 vaccine

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem. The Food and Drug Administration announced the new warning, flagging reports of Guillain-Barre syndrome, an immune system disorder that can causes muscle weakness and occasionally paralysis. Health officials described the side effect as a small possible risk" for those getting the shot. The action comes after the FDA and the Centers for Disease Control and Prevention reviewed reports of about 100 people developing the syndrome after receiving the one-dose vaccine. Almost all of them required hospitalization and one person died, the FDA said. Guillain-Barre syndrome occurs when the body's immune system mistakenly attacks some of its nerve cells, causing muscle weakness and sometimes paralysis that typically is temporary. An estimated 3,000 to 6,000 people develop the ..

A bottleneck in the vaccine chain

Prosenjit Datta points to a possible crisis as the government moves to improve supplies of Covid vaccines: inadequate testing facilities to handle those volumes

Pfizer, J&J vaccines more effective against Delta variant: Experts

Delta variant, first detected in India, is driving the current third wave in South Africa

Johnson & Johnson's one shot Covid vax effective against Delta variant

The vaccine is 85 per cent effective against severe/critical disease and demonstrated protection against hospitalisation and death from the deadly coronavirus.

J&J's single-dose Covid vaccine shows promising signs against Delta variant

Johnson & Johnson on Thursday (local time) announced that its single-shot COVID-19 vaccine showed promising signs of protection against the Delta variant rapidly spreading across the US and other countries, in a small laboratory study.According to the company report, the vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the immune response lasted through at least eight months, the length of time evaluated to date. The two preprint study summaries have been submitted today to bioRxiv, a non-profit preprint server for the life sciences.The single-dose vaccine, elicited neutralising antibody activity against the Delta variant at an even higher level than what was recently observed for the Beta (B.1.351) variant in South Africa, the report stated.In the ensemble trial, Johnson & Johnson's vaccine was 85 per cent effective against ...

EU approves new one-dose J&J Covid-19 vaccine production site

The European Medicines Agency has approved a new manufacturing site for Johnson & Johnson's COVID-19 vaccine, in a move that should boost production of the one-dose vaccine across the 27-nation EU. In a statement Friday, the EU drug regulator said the new site in Anagni, Italy, will finish manufacturing of the J&J vaccine, which was licensed for use in adults across Europe in March. Production problems have stalled J&J's roll-out across the European Union in recent months and millions of doses made at a U.S. factory had to be thrown out after contamination issues. The EU has ordered 200 million doses of the J&J vaccine and was expecting 55 million by the end of June; to date, fewer than 14 million doses have been distributed. J&J's vaccine roll-out was also stalled after the EMA concluded there was a possible link between the coronavirus shot and very rare blood clots and recommended that a warning should be added to the label. Health officials say the vaccine's ...

World Coronavirus Dispatch: Virus rips through Southeast Asian workers

The case for widespread use of sniffing dogs to detect Covid, Britain's PM Johnson hints at delay to end of lockdown, and other pandemic-related news across the globe

Maldives gives emergency approval to Moderna, J&J Covid-19 vaccines

The Maldives Food and Drug Administration (MFDA) has given emergency approval to the Covid-19 vaccines by Moderna and Johnson & Johnson as the island nation continues to battle the third wave of the pandemic.

Weary seafarers come ashore in US for J&J one-dose Covid vaccine shots

It is the preferred vaccine for maritime workers because they're often docked for just a day or two at a port.

Govt looking into securing part of J&J vaccines for Indian market: Report

Johnson and Johnson's COVID-19 vaccine to be manufactured in India by Biological E cannot be directly channelled to the domestic market and will have to be handed over entirely to the US pharma giant as agreed by the firms but the government is looking at the possibility of securing a part of this production, sources said. Hyderabad-based Biological E has, however, proposed to manufacture about 30 crore doses of its indigenous vaccine exclusively for the Indian market by December and has sought "funding support" from the government. Its vaccine candidate is currently in phase 1/2 clinical trial phase. According to the sources, there are limited prospects of J&J exporting its vaccine from the US to other countries in the near future and the "entire production" at the BE facilities in India, beginning July/August, will be handed over to the pharma giant under a contract between the companies. The Ministry of External Affairs (MEA), along with the Department of Biotechnology (DBT), ..

Centre steps in after foreign Covid-19 vaccine makers say no to state govts

Union govt in direct talks with firms but order book full for now

J&J to resume rollout of Covid-19 vaccine in Europe with safety warning

(Reuters) -Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region's medical regulator said the benefits of the shot outweigh the risk of very rare, potentially lethal blood clots.

J&J reports $100 million in vaccine sales as results top forecasts

The United States is also reviewing a handful of potential cases of severe side effects in addition to those that led to the pause

Govt fast-tracks Covid-19 fight, to start vaccination for 18+ from May 1

States allowed to procure directly from manufacturers; open market supply permitted

From Sputnik V to Moderna, here's a snapshot of Covid-19 vaccines

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the aforementioned criteria

Decision in 3 working days after foreign Covid-19 vaccine firms apply

Many vaccine makers in talks with govt as India wants a portfolio of products